GOSERELIN INHIBITING UPTAKE ON SODIUM PERTECHNETATE Tc-99M THYROID SCAN: A CASE REPORT

Annals of Ibadan postgraduate medicine · 2024 · vol. 22(1) , pp. 100–103 · PMID:38939893 · PMC11205726
other OA: gold public-domain-us
📄 Open PDF View on PubMed

Abstract

INTRODUCTION: Thyroiditis may be induced by goserelin (a long acting analogue of gonadotropin - releasing hormone) prescribed for the treatment of pain and bleeding of endometriosis. Goserelin induced thyroiditis has a possibility of affecting thyroid function and hence may cause poor uptake on sodium pertechnetate Tc-99m thyroid scan. RESULTS: This case report highlights a rare instance of a middle-aged woman with symptomatic toxic goitre whose sodium pertechnetate Tc-99m thyroid scan uptake was inhibited by goserelin therapy. CONCLUSION: Medical personnel caring for patients on goserelin need to be aware of the possibility of it affecting thyroid function.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-06-22T06:15:23.361955+00:00
pubmed
last seen: 2026-06-11T06:17:30.685761+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine